Current Surgical Therapy for Bronchiectasis: Surgical Results and Predictive Factors in 86 Patients

Balcı, Akın Eraslan; Balcı, Tansel Ansal; Özyurtan, Mehmet Oğuzhan

doi:10.1016/j.athoracsur.2013.09.013

Cited by 36 publications

(37 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[18,25,33,34] In our series, we observed nearly equal morbidity rates for our adult and pediatric patients who were treated surgically (27.6% and 25.3%, respectively; p>0.05), and most complications were minor, such as transient atelectasis or prolonged air leakage. The mortality rates after surgical treatment for bronchiectasis in adults are relatively low, ranging from 0 to 2.2%, [3,4,12,[22][23][24][30][31][32] while these rates are between 0 and 5.6% in pediatric cases. [18,25,33,34] In our study, there was no intra-or postoperative mortality in either group.…”

Section: Discussionmentioning

confidence: 99%

“…[3,4,12,[22][23][24][30][31][32] Some authors have also reported morbidity rates ranging between 7.4 and 36% for pediatric patients. [18,25,33,34] In our series, we observed nearly equal morbidity rates for our adult and pediatric patients who were treated surgically (27.6% and 25.3%, respectively; p>0.05), and most complications were minor, such as transient atelectasis or prolonged air leakage.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The role of current surgical therapy for pediatric/adolescent and adult patients with bronchiectasis

Ulutaş¹

2017

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

ÖZAmaç: Bu çalışmada, bronşektazili çocuk ve erişkin hastalarda klinik bulgular, cerrahi endikasyonlar, cerrahi işlemler, ameliyat sonrası komplikasyonlar ve cerrahi tedavi sonuçları karşılaştırıldı.Ça lış ma pla nı: Ocak 2000 -Aralık 2013 tarihleri arasında bronşektazi nedeni ile Göğüs Cerrahisi bölümünde ameliyat edilen toplam 99 hasta (40 erkek, 59 kadın; ort. yaş 33.3 yıl; dağılım 10-67 yıl) geriye dönük olarak incelendi. Grup 1 (n=28) çocuk hastalardan (≤18 yıl) ve grup 2 (n=71) erişkin hastalardan (>18 yıl) oluşuyor idi. Klinik semptomlar, yapılan cerrahi tedavi kriterleri, cerrahi tedavi yaklaşımları, ameliyat sonrası komplikasyonlar, hastanede kalış süreleri ve tedavi sonuçları değerlendirildi. Bul gu lar:Her iki grupta en yaygın semptom prodüktif öksürüğü takiben tekrarlayan enfeksiyonlar idi. Gruplar arasında bu semptomların görülme sıklığı açısından anlamlı bir fark saptanmadı. Toplamda 104 cerrahi yapıldı. Grup 1'de 29 cerrahinin 26'sı torakotomi ve üçü video yardımlı torakoskopik cerrahi idi. Grup 2'de 75 cerrahinin 60'ı torakotomi ve 15'i video yardımlı torakoskopik cerrahi idi. Grup 1'de sekiz ameliyatta (27.6%) ve grup 2'de 18 ameliyatta (24%) ameliyat sonrası komplikasyonlar izlendi. Ameliyat sırası ve sonrası mortalite gözlenmedi. Grup 1'de 28 hastanın tamamında ameliyat sonrası iyileşme izlenir iken, 23 sonuç (%82.1) mükemmel (tam remisyon) ve beş sonuç (%17.9) iyileşmiş (semptomlarda azalma) olarak tanımlandı. Grup 2'de 63 sonuç (%88.7) mükemmel ve yedi sonuç (%9.9) iyileşmiş olarak tanımlandı; ancak bir hastada (1.4%) iyileşme izlenmedi.So nuç: Seçilmiş olgularda, hastanın yaşından bağımsız olarak, bronşektazinin cerrahi tedavisi tatmin edicidir ve kabul edilebilir mortalite ve morbidite oranları ile ilişkilidir. Çalışma sonuçlarımıza göre, cerrahi bu hastalığı tedavi edebilir ve tedavi edemediği durumlarda dahi, hastanın yaşam kalitesini iyileştirebilir.Anah tar söz cük ler: Erişkin bronşektazisi; pediatrik bronşektazi; cerrahi tedavi. ABSTRACTBackground:This study aims to compare clinical manifestations, surgical indications, surgical procedures, postoperative complications, and outcomes of surgical treatment in pediatric and adult patients with bronchiectasis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The role of current surgical therapy for pediatric/adolescent and adult patients with bronchiectasis

Ulutaş¹

2017

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

show abstract

“…In cases of bronchiectasis related to an obstructing endobronchial lesion, removal of the lesion does not reverse the bronchial dilatation but can lead to improvement of symptoms and prevent further bronchial enlargement. In cases of severe bronchiectasis limited to a segment or lobe, surgical resection can be performed (12).…”

Section: Features Of Bronchiectasismentioning

confidence: 99%

Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases

Milliron¹,

Henry²,

Veeraraghavan³

et al. 2015

RadioGraphics

107

View full text Add to dashboard Cite

Bronchiectasis is permanent irreversible dilatation of the airways and occurs in a variety of pathologic processes. Recurrent infection and inflammation and the resulting chemical and cellular cascade lead to permanent architectural changes in the airways. Bronchiectasis can confer substantial potential morbidity, usually secondary to recurrent infection. In severe cases of bronchiectasis, massive hemoptysis can lead to death. Thin-section computed tomography is the most sensitive imaging modality for the detection of bronchiectasis; findings include bronchial diameter exceeding that of the adjacent pulmonary artery and lack of normal tapering of terminal bronchioles as they course toward the lung periphery. The authors will review various causes of bronchiectasis, including common causes, such as recurrent infection or aspiration, and uncommon causes, such as congenital immunodeficiencies and disorders of cartilage development. The authors will also present an approach emphasizing the distribution (apical versus basal and central versus peripheral) and concomitant findings, such as nodules, cavities, and/or lymphadenopathy, that can assist in narrowing the differential diagnosis. Although an adequate understanding of these underlying causes in conjunction with their specific imaging appearances will allow radiologists to more confidently determine the process causing this common radiologic finding, clinical history and patient demographic characteristics play an integral role in determining a pertinent and concise differential diagnosis.

show abstract

“…Surgical intervention is uncommon in children. However, those with severe, poorly controlled, localized disease, or recurrent hemoptysis may require surgical resection of a bronchiectatic lobe …”

Section: Treatments For Bronchiectasis (References In the Text)mentioning

confidence: 99%

“…However, those with severe, poorly controlled, localized disease, or recurrent hemoptysis may require surgical resection of a bronchiectatic lobe. [173][174][175][176] Education Treatment adherence in adults with bronchiectasis is poor (16%), but those who adhere to treatment have fewer exacerbations and lower treatment burden scores. 177 Therefore the importance of adherence with airway clearance techniques and maintenance therapy needs to be monitored and its importance reinforced on a regular basis.…”

Section: Surgerymentioning

confidence: 99%

Pediatric bronchiectasis: No longer an orphan disease

Goyal

Grimwood

Marchant

et al. 2016

Pediatric Pulmonology

131

140

View full text Add to dashboard Cite

Bronchiectasis is described classically as a chronic pulmonary disorder characterized by a persistent productive cough and irreversible dilatation of one or more bronchi. However, in children unable to expectorate, cough may instead be wet and intermittent and bronchial dilatation reversible in the early stages. Although still considered an orphan disease, it is being recognized increasingly as causing significant morbidity and mortality in children and adults in both affluent and developing countries. While bronchiectasis has multiple etiologies, the final common pathway involves a complex interplay between the host, respiratory pathogens and environmental factors. These interactions lead to a vicious cycle of repeated infections, airway inflammation and tissue remodelling resulting in impaired airway clearance, destruction of structural elements within the bronchial wall causing them to become dilated and small airway obstruction. In this review, the current knowledge of the epidemiology, pathobiology, clinical features, and management of bronchiectasis in children are summarized. Recent evidence has emerged to improve our understanding of this heterogeneous disease including the role of viruses, and how antibiotics, novel drugs, antiviral agents, and vaccines might be used. Importantly, the management is no longer dependent upon extrapolating from the cystic fibrosis experience. Nevertheless, substantial information gaps remain in determining the underlying disease mechanisms that initiate and sustain the pathophysiological pathways leading to bronchiectasis. National and international collaborations, standardizing definitions of clinical and research end points, and exploring novel primary prevention strategies are needed if further progress is to be made in understanding, treating and even preventing this often life-limiting disease.

show abstract

Current Surgical Therapy for Bronchiectasis: Surgical Results and Predictive Factors in 86 Patients

Cited by 36 publications

References 13 publications

The role of current surgical therapy for pediatric/adolescent and adult patients with bronchiectasis

The role of current surgical therapy for pediatric/adolescent and adult patients with bronchiectasis

Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases

Pediatric bronchiectasis: No longer an orphan disease

Contact Info

Product

Resources

About